John C. Morris
#124,946
Most Influential Person Now
John C. Morris's AcademicInfluence.com Rankings
John C. Morrismedical Degrees
Medical
#1980
World Rank
#2368
Historical Rank
Neurology
#192
World Rank
#265
Historical Rank
John C. Morrisphilosophy Degrees
Philosophy
#5821
World Rank
#8730
Historical Rank
Logic
#3032
World Rank
#4128
Historical Rank
Download Badge
Medical Philosophy
Why Is John C. Morris Influential?
(Suggest an Edit or Addition)John C. Morris's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The Clinical Dementia Rating (CDR) (1993) (5450)
- Current concepts in mild cognitive impairment. (2001) (4482)
- Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. (2002) (3080)
- Mild cognitive impairment represents early-stage Alzheimer disease. (2001) (1743)
- Clinical Dementia Rating: A Reliable and Valid Diagnostic and Staging Measure for Dementia of the Alzheimer Type (1997) (1180)
- Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. (1998) (951)
- Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. (1997) (924)
- The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) (1994) (924)
- The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease (1991) (814)
- [11C]PIB in a nondemented population (2006) (767)
- The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) (1993) (671)
- Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. (1998) (632)
- Cerebral amyloid deposition and diffuse plaques in ``normal'' aging (1996) (600)
- Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study. (1997) (592)
- Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease. (2001) (569)
- Normative estimates of cross-sectional and longitudinal brain volume decline in aging and AD (2005) (512)
- A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients (2001) (497)
- The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families (1995) (461)
- Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease (1996) (402)
- Rofecoxib: No effect on Alzheimer’s disease in a 1-year, randomized, blinded, controlled study (2004) (375)
- Very mild Alzheimer's disease (1991) (372)
- Senile dementia of the Alzheimer's type: an important risk factor for serious falls. (1987) (345)
- Reliability of the Washington University Clinical Dementia Rating. (1988) (325)
- A prospective study of cognitive function and onset of dementia in cognitively healthy elders. (1998) (323)
- Clinical Dementia Rating training and reliability in multicenter studies (1997) (315)
- Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease (1998) (286)
- Variability in annual Mini-Mental State Examination score in patients with probable Alzheimer disease: a clinical perspective of data from the Consortium to Establish a Registry for Alzheimer's Disease. (1999) (270)
- Early DAT is distinguished from aging by high-dimensional mapping of the hippocampus (2000) (266)
- Neuropathological indexes of Alzheimer's disease in demented and nondemented persons aged 80 years and older. (1993) (265)
- The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part XIII. (1996) (251)
- Driving Performance in Persons with Mild Senile Dementia of the Alzheimer Type (1993) (242)
- Very mild senile dementia of the Alzheimer type. I. Clinical assessment. (1989) (231)
- Advanced Alzheimer's disease is a risk factor for late-onset seizures. (1990) (226)
- Aphasia in senile dementia of the alzheimer type (1988) (220)
- Reliability of the Washington University Road Test. A performance-based assessment for drivers with dementia of the Alzheimer type. (1997) (216)
- The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). (1995) (205)
- Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia. (2001) (200)
- Alzheimer disease and cancer (2005) (198)
- Attention and driving performance in Alzheimer's disease. (1998) (191)
- Periventricular white matter lucencies in senile dementia of the Alzheimer type and in normal aging (1987) (186)
- The association of ventral tegmental area histopathology with adult dementia. (1988) (184)
- Adrenal hemorrhage: a 25-year experience at the Mayo Clinic. (2001) (181)
- Mild senile dementia of the alzheimer type: 2. Longitudinal assessment (1988) (177)
- The pathogenesis of Graves' disease. (1998) (171)
- The value of informant versus individual's complaints of memory impairment in early dementia (2000) (171)
- Motor dysfunction in mildly demented AD individuals without extrapyramidal signs (1999) (161)
- Clinical and pathological aspects of parkinsonism in Alzheimer's disease. A role for extranigral factors? (1989) (159)
- Progressive aphasia (1990) (157)
- The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs (2005) (156)
- Increased neocortical neurofibrillary tangle density in subjects with Alzheimer disease and psychosis. (2000) (154)
- A longitudinal study of drivers with Alzheimer disease (2008) (153)
- Increased risk of dementia in mothers of Alzheimer's disease cases (1996) (151)
- Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene. (1998) (147)
- Absence of cognitive impairment or decline in preclinical Alzheimer’s disease (2001) (143)
- Hereditary dysphasic disinhibition dementia A frontotemporal dementia linked to 17 q21‐‐22 (1998) (142)
- Current concepts in the pathogenesis of Alzheimer's disease. (1997) (141)
- The clock drawing test is a poor screen for very mild dementia (2002) (135)
- Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success? (2001) (128)
- Preclinical trials in autosomal dominant AD: implementation of the DIAN-TU trial. (2013) (127)
- Hereditary dysphasic dementia and the Pick‐Alzheimer spectrum (1984) (126)
- Rapid activation of astrocyte-specific expression of GFAP-lacZ transgene by focal injury. (1991) (126)
- Relating anatomy to function in Alzheimer's disease (1998) (125)
- Harmonized diagnostic criteria for Alzheimer's disease: recommendations (2014) (118)
- Auditory dysfunction in aging and senile dementia of the Alzheimer's type. (1995) (117)
- Mild senile dementia of the Alzheimer type. 4. Evaluation of intervention (1992) (114)
- Contribution of APOE promoter polymorphisms to Alzheimer’s disease risk (2002) (112)
- Complement Activation in Very Early Alzheimer Disease (2005) (111)
- Reliability of clinical nurse specialists in the staging of dementia. (1989) (109)
- Clinical and neuropsychological differences between patients with earlier and later onset of Alzheimer's disease (1996) (109)
- Resting bold fMRI differentiates dementia with Lewy bodies vs Alzheimer disease (2011) (106)
- Cancer linked to Alzheimer disease but not vascular dementia (2010) (103)
- CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease (2012) (100)
- Cognitive and motor functioning in Parkinson disease: subjects with and without questionable dementia. (1998) (100)
- Estimating the validity of the Clinical Dementia Rating Scale: The CERAD experience (1996) (97)
- The diagnosis of Alzheimer's disease. (1996) (88)
- Clinical-neuropathologic findings in multi-infarct dementia (1997) (87)
- Understanding of informed consent by demented individuals (2003) (85)
- SYMPTOMS OF “DEPRESSION” IN DEMENTIA OF THE ALZHEIMER TYPE (1988) (81)
- Evidence That Age-Associated Memory Impairment Is Not a Normal Variant of Aging (2001) (74)
- CSF excitatory amino acids and severity of illness in Alzheimer's disease (1996) (74)
- Alcohol withdrawal seizures. (1987) (73)
- Blinded clinical evaluation of positron emission tomography for diagnosis of probable Alzheimer's disease (1992) (72)
- American Academy of Neurology position statement on physician reporting of medical conditions that may affect driving competence (2007) (67)
- Clinical global measures of dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. (1997) (61)
- Early Alzheimer's disease. Diagnostic considerations. (1988) (60)
- The Role of Selective Attention in Driving and Dementia of the Alzheimer Type (1997) (58)
- Brief Screening Tests versus Clinical Staging in Senile Dementia of the Alzheimer Type (1990) (58)
- Effect of APOE genotype and promoter polymorphism on risk of Alzheimer's disease (2000) (56)
- Labeled cortical mantle distance maps of the cingulate quantify differences between dementia of the Alzheimer type and healthy aging (2003) (52)
- The neurology of aging: normal versus pathologic change. (1991) (52)
- Differences in the Abeta40/Abeta42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype. (2000) (52)
- Suggestive synergy between genetic variants in TF and HFE as risk factors for Alzheimer's disease (2009) (51)
- Is Alzheimer's disease inevitable with age?: Lessons from clinicopathologic studies of healthy aging and very mild alzheimer's disease. (1999) (51)
- Interlaboratory Histopathologic Assessment of Alzheimer Neuropathology: Different Methodologies Yield Comparable Diagnostic Results (1993) (50)
- Cognitive profiles in dementia (2008) (49)
- Mesolimbocortical dementia. A clinicopathologic case study of a putative disorder. (1986) (49)
- The relationship between extrapyramidal signs and cognitive performance in patients with Alzheimer's disease enrolled in the CERAD study (1997) (48)
- Cognitively unimpaired HIV-positive subjects do not have increased 11C-PiB (2010) (48)
- Clinical Evaluation of Global Change in Alzheimer's Disease: Identifying Consensus (1996) (47)
- Combined PET/MRI: Global Warming—Summary Report of the 6th International Workshop on PET/MRI, March 27–29, 2017, Tübingen, Germany (2017) (46)
- Gene therapy for prostate cancer: current status and future prospects. (2001) (44)
- An update on primary drug therapies for Alzheimer disease. (1997) (43)
- Autosomal dominant Kufs' disease: a cause of early onset dementia (2001) (41)
- Rofecoxib (2004) (39)
- Aging and cerebrovascular disease. (1998) (39)
- The CERAD experience, part VIII (1995) (37)
- Meta-analysis of genetic association with diagnosed Alzheimer’s disease identifies novel risk loci and implicates Abeta, Tau, immunity and lipid processing (2018) (36)
- Clinical trials in Alzheimer disease: debate on the use of placebo controls. (1999) (36)
- So what if tangles precede plaques? (2004) (35)
- Clinical diagnosis and course of Alzheimer's disease. (1991) (35)
- Senile dementia and healthy aging: a longitudinal CT study. (1991) (34)
- Alzheimer disease identification using amyloid imaging and reserve variables (2010) (34)
- A multicenter, randomized, placebo controlled, multiple-dose, safety and pharmacokinetic study of AIT-082 (Neotrofin) in mild Alzheimer's disease patients. (2003) (34)
- Influence of age on clinical and psychometric assessment of subjects with very mild or mild dementia of the Alzheimer type. (1993) (33)
- The nosology of dementia. (2000) (32)
- Psychopathology in younger versus older persons with very mild and mild dementia of the Alzheimer type. (1993) (31)
- Familial dementia with Lewy bodies: clinicopathologic analysis of two kindreds. (2002) (31)
- Tyrosine hydroxylase-like (TH) immunoreactivity in Parkinson's disease and Alzheimer's disease (1992) (29)
- Home-based multidisciplinary diagnosis and treatment of inner-city elders with dementia. (1999) (25)
- Reversible paraneoplastic limbic encephalitis (1993) (22)
- Alpha-2 macroglobulin gene and Alzheimer disease. (1999) (19)
- TDP‐43 proteinopathy in familial motor neurone disease with TARDBP A315T mutation: a case report (2010) (18)
- Cognitive speed in nondemented Parkinson's disease (1998) (17)
- Thalamic amnesia: Korsakoff syndrome due to left thalamic infarction (1992) (17)
- Therapeutic continuity in Alzheimer's disease: switching patients to galantamine. Introduction. (2001) (16)
- The Challenge of Characterizing Normal Brain Aging in Relation to Alzheimer’s Disease (1997) (15)
- Differential diagnosis of Alzheimer's disease. (1994) (14)
- Binswanger's disease or artifact: a clinical, neuroimaging, and pathological study of periventricular white matter changes in Alzheimer's disease. (1990) (14)
- Translation issues in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. (1997) (13)
- Promoting interactions with basic scientists and clinicians: the NIA Alzheimer's Disease Data Coordinating Center. (2000) (13)
- Alzheimer's disease: a review of clinical assessment and management issues. (1997) (11)
- Semantic dementia versus Alzheimer’s disease (2001) (8)
- Is Now the Time for Combination Therapies for Alzheimer Disease? (2019) (7)
- How Will Aducanumab Approval Impact AD Research? (2021) (6)
- Therapeutic continuity in Alzheimer's disease: switching patients to galantamine. Panel discussion: recommendations for prescribers. (2001) (6)
- Molecular genetics of hereditary dysphasic dementia (1994) (6)
- AT(N) predicts near-term development of Alzheimer's disease symptoms in unimpaired older adults (2022) (4)
- A New Era: Disease Modifying Alzheimer Disease Prevention Trials. (2014) (2)
- Structural signature of sporadic Creutzfeldt–Jakob disease (2019) (2)
- Tau positron emission tomography imaging in C9orf72 repeat expansion carriers (2019) (2)
- Vascular glycosaminoglycans in periventricular leukoencephalopathy (2004) (2)
- Minimizing the Sample Sizes of Clinical Trials on Preclinical and Early Symptomatic Stage of Alzheimer Disease (2018) (2)
- Activating mutations of the thyrotropin receptor--unanswered questions. (1996) (2)
- 4-42-05 Metrifonate: Potential therapy for Alzheimer's disease (1997) (1)
- HDDD with Alzheimer's disease as common comorbidity: A clinicopathologic case report (2009) (1)
- Disclosure of financial interest: a new policy for Alzheimer disease and associated disorders. (1996) (1)
- Clinical and multimodal biomarker correlates of ADNI neuropathological findings (2013) (1)
- Mutations and disorders involving the thyroid iodide transporter--the next wave in thyroid diseases. (1997) (1)
- Immune response, safety, and overall survival of NY-ESO-1+ soft tissue sarcoma patients treated with CMB305 therapy. (2018) (1)
- No cell loss in the entorhinal cortex in preclinical Alzheimers disease (1999) (1)
- 495 Association studies between late onset Alzheimer's Disease and the genes encoding the brain receptors for ApoE in a Caucasian population (1996) (0)
- Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease (2018) (0)
- International research initiatives in Alzheimer’s disease (2019) (0)
- High-dose Phenylephrine and Ephedrine in Obstetrics: Proving the Holy Grail Requires More Data (2010) (0)
- Cross-omics integration shows cortex-wide synaptic dysfunction at later stages of Alzheimer disease (2022) (0)
- Proteome Wide Association Studies of LRRK2 variants identify novel causal and druggable for Parkinsons disease (2023) (0)
- Practice Concepts and Policy Analysis An Interdisciplinary Outreach Model of African American Recruitment for Alzheimer’s Disease Research (2011) (0)
- 63-year-old woman with fever and right flank pain. (1996) (0)
- Apolipoprotein E ɛ4–related effects on cognition are limited to the Alzheimer’s disease spectrum (2021) (0)
- Clinically early-stage CSPα mutation carrier exhibits remarkable terminal stage neuronal pathology with minimal evidence of synaptic loss (2015) (0)
- Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies (2020) (0)
- Genome-wide association, Mendelian Randomization and polygenic risk score studies converge on a role of beta-amyloid and APOE locus in Parkinson disease (2020) (0)
- TYROSINE-HYDROXYLASE-LIKE (TH) IMMUNOREACTIVITY OF HIPPOCAMPAL FORMATION IN ADULT DEMENTIA: 258 (1990) (0)
- Apolipoprotein E ɛ4–related effects on cognition are limited to the Alzheimer’s disease spectrum (2021) (0)
- Adaptation of the Clinical Dementia Rating Scale for adults with Down syndrome (2019) (0)
- The 2001 Potamkin Prize winner. (2001) (0)
This paper list is powered by the following services:
